<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Effect estimates, event rates, and numbers needed to treat (NNT) of meta-analyses examining medical cannabinoids versus placebo or other antiemetics for nausea and vomiting in chemotherapy (or in palliative patients for Mücke et al&lt;sup&gt;[1]&lt;/sup&gt;)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Effect estimates, event rates, and numbers needed to treat (NNT) of meta-analyses examining medical cannabinoids versus placebo or other antiemetics for nausea and vomiting in chemotherapy (or in palliative patients for Mücke et al<sup>[1]</sup>)</h1>
<div class="graphic"><div class="figure"><div class="ttl">Effect estimates, event rates, and numbers needed to treat (NNT) of meta-analyses examining medical cannabinoids versus placebo or other antiemetics for nausea and vomiting in chemotherapy (or in palliative patients for Mücke et al<sup>[1]</sup>)</div><div class="cntnt"><table cellspacing="0"><colgroup span="8" width="12%"></colgroup> <tbody> <tr> <td class="subtitle1_left">Systematic review</td> <td class="subtitle1_left">Outcome (comparison)</td> <td class="subtitle1_left">No. of RCTs (no. of participants)</td> <td class="subtitle1_left">Authors' meta-analysis result (95% CI), heterogeneity</td> <td class="subtitle1_left">Meta-analysis re-analyzed (95% CI), heterogeneity</td> <td class="subtitle1_left">Cannabinoid event rate, %</td> <td class="subtitle1_left">Control event rate, %</td> <td class="subtitle1_left">NNT</td> </tr> <tr> <td>Whiting et al, 2015<sup>[2]</sup></td> <td>Nausea and vomiting—complete response (versus placebo)</td> <td>3 (102)</td> <td>OR = 3.82 (1.55 to 9.42), <em>I</em><sup>[2]</sup> = 0%</td> <td>RR = 2.43 (1.30 to 4.52), <em>I</em><sup>[2]</sup> = 0%</td> <td>47</td> <td>20</td> <td>4</td> </tr> <tr class="highlight_lght_gray_text"> <td rowspan="4">Smith et al, 2015<sup>[3]</sup></td> <td>Absence of nausea and vomiting (versus placebo)</td> <td>3 (288)</td> <td>RR = 2.86 (1.76 to 4.65), <em>I</em><sup>[2]</sup> = 0%</td> <td>NA</td> <td>37</td> <td>12</td> <td>4</td> </tr> <tr class="highlight_lght_gray_text"> <td>Patient preference (versus placebo)</td> <td>2 (256)</td> <td>RR = 4.82 (1.74 to 13.36), <em>I</em><sup>[2]</sup> = 69%</td> <td>NA</td> <td>72</td> <td>18</td> <td>2</td> </tr> <tr class="highlight_lght_gray_text"> <td>Absence of nausea and vomiting (versus prochlorperazine)</td> <td>4 (414)</td> <td>RR = 2.00 (0.74 to 5.38), <em>I</em><sup>[2]</sup> = 60%</td> <td>NA</td> <td>20</td> <td>11</td> <td>NS</td> </tr> <tr class="highlight_lght_gray_text"> <td>Patient preference (versus other drugs)</td> <td>9 (799)</td> <td>RR = 2.76 (1.88 to 4.03), <em>I</em><sup>[2]</sup> = 61%</td> <td>NA</td> <td>63</td> <td>19</td> <td>3</td> </tr> <tr> <td>Mücke et al, 2016<sup>[1]</sup></td> <td>Improvement in nausea and vomiting symptoms (versus placebo)*</td> <td>2 (307)</td> <td>SMD = 0.20 (–0.03 to 0.44), <em>I</em><sup>[2]</sup> = 0%</td> <td>NA</td> <td>NA</td> <td>NA</td> <td>NA</td> </tr> <tr class="highlight_lght_gray_text"> <td rowspan="3">Machado Rocha et al, 2008<sup>[4]</sup></td> <td>Nausea and vomiting within 1 day of chemotherapy (dronabinol versus placebo)</td> <td>2 (185)</td> <td>RR = 0.47 (0.19 to 1.16), <em>I</em><sup>[2]</sup> = 91%</td> <td>NA</td> <td>40</td> <td>87</td> <td>NS</td> </tr> <tr class="highlight_lght_gray_text"> <td>Nausea and vomiting within 1 day of chemotherapy (dronabinol versus neuroleptics)</td> <td>5 (325)</td> <td>RR = 0.67 (0.47 to 0.96), <em>I</em><sup>[2]</sup> = 79%</td> <td>NA</td> <td>52</td> <td>80</td> <td>4</td> </tr> <tr class="highlight_lght_gray_text"> <td>Nausea and vomiting within 1 day of chemotherapy (nabilone versus neuroleptics)</td> <td>6 (277)</td> <td>RR = 0.88 (0.72 to 1.08), <em>I</em><sup>[2]</sup> = 64%</td> <td>NA</td> <td>75</td> <td>85</td> <td>NS</td> </tr> <tr> <td rowspan="6">Tramèr et al, 2001<sup>[5]</sup></td> <td>Control of nausea (versus placebo)</td> <td>4 (231)</td> <td>RelR = 1.21 (1.03 to 1.42), <em>I</em><sup>[2]</sup> = NR</td> <td>NA</td> <td>70</td> <td>57</td> <td>8</td> </tr> <tr> <td>Control of vomiting (versus placebo)</td> <td>4 (231)</td> <td>RelR = 1.84 (1.42 to 2.38), <em>I</em><sup>[2]</sup> = NR</td> <td>NA</td> <td>66</td> <td>36</td> <td>4</td> </tr> <tr> <td>Control of nausea (versus antiemetic)</td> <td>7 (422)</td> <td>RelR = 1.38 (1.18 to 1.62), <em>I</em><sup>[2]</sup> = NR</td> <td>NA</td> <td>59</td> <td>43</td> <td>7</td> </tr> <tr> <td>Control of vomiting (versus antiemetic)</td> <td>6 (395)</td> <td>RelR = 1.28 (1.08 to 1.51), <em>I</em><sup>[2]</sup> = NR</td> <td>NA</td> <td>57</td> <td>45</td> <td>9</td> </tr> <tr> <td>Patient preference (versus placebo)</td> <td>4 (404)</td> <td>RelR = 5.67 (3.95 to 8.15), <em>I</em><sup>[2]</sup> = NR</td> <td>NA</td> <td>76</td> <td>13</td> <td>2</td> </tr> <tr> <td>Patient preference (versus antiemetic)</td> <td>14 (1212)</td> <td>RelR = 2.39 (2.05 to 2.78), <em>I</em><sup>[2]</sup> = NR</td> <td>NA</td> <td>61</td> <td>26</td> <td>3</td> </tr> <tr class="highlight_lght_gray_text"> <td rowspan="2">All studies</td> <td>Control of nausea and vomiting (versus placebo)</td> <td>7 (500)</td> <td>NA</td> <td>RR = 3.60 (2.55 to 5.09), <em>I</em><sup>[2]</sup> = 18%</td> <td>47</td> <td>13</td> <td>3</td> </tr> <tr class="highlight_lght_gray_text"> <td>Control of nausea and vomiting (versus antiemetics)</td> <td>14 (1022)</td> <td>NA</td> <td>RR = 1.85 (1.18 to 2.91), <em>I</em><sup>[2]</sup> = 60%</td> <td>31</td> <td>16</td> <td>7</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>NA: not applicable; NNT: number needed to treat; NR: not reported; NS: not significant; OR: odds ratio; RCT: randomized controlled trial; RelR: relative risk; RR: risk ratio; SMD: standardized mean difference.</p>
* This was for palliative patients (1 HIV RCT and 1 refractory cancer pain RCT).</div><div class="graphic_reference">References:
<ol>
<li>Mücke M, Carter C, Cuhls H, et al. Cannabinoids in palliative care: systematic review and meta-analysis of efficacy, tolerability and safety. Schmerz 2016; 30:25.</li>
<li>Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015; 313:2456.</li>
<li>Smith LA, Azariah F, Lavender VT, et al. Cannabinoids for nausea andvomiting in adults with cancer receiving chemotherapy. Cochrane Database Syst Rev 2015; 11:CD009464.</li>
<li>Machado Rocha FC, Stéfano SC, De Cássia Haiek R, et al. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomitingamong cancer patients: systematic review and meta-analysis. Eur J Cancer Care 2008; 17:431.</li>
<li>Tramèr MR, Carroll D, Campbell FA, et al. Cannabinoidsfor control of chemotherapy induced nausea and vomiting: quantitative systematicreview. BMJ 2001; 323:16.</li>
</ol>
<p class="extra_spacing_top">Reproduced with permission from: Allan GM, Finley CR, Ton J, et al. Systematic review of systematic reviews for medical cannabinoids: Pain, nausea and vomiting, spasticity, and harms. Can Fam Physician 2018; 64:e78. Copyright © 2018 The College of Family Physicians of Canada.</p></div><div id="graphicVersion">Graphic 139106 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
